🔴 Structure Therapeutics is trading 5% down today as biotech and broader markets sold off

Structure Therapeutics is trading 5.32% down at $21.01 on October 16, 2026, amid biotech and broader market weakness; no fresh company-specific catalyst was identified.

• The decline extends a sharp recent slide, with shares trading near a reported 52-week low.
• Biotech ETF XBI is down 2.06%; afternoon technology pressure pulled major indexes lower amid broader market selling.